维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="Hendlisz"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Radioembolisation and portal vein embolization before resection of large hepatocellular carcinoma显示文摘Resectability of hepatocellular carcinoma in patients with chronic liver disease is dramatically limited by the need to preserve sufficient remnant liver in order to avoid postoperative liver insufficiency. Preoperative treatments aimed at downsizing the tumor and promoting hypertrophy of the future remnant liver may improve resectability and reduce operative morbidity. Here we report the case of a patient with a large hepatocellular carcinoma arising from chronic liver disease. Preoperative treatment, including tumor downsizing with transarterial radioembolization and induction of future remnant liver hypertrophy with right portal vein embolization, resulted in a 53% reduction in tumor volume and compensatory hypertrophy in the contralateral liver. The patient subsequently underwent extended right hepatectomy with no postoperativesigns of liver decompensation. Pathological examination demonstrated a margin-free resection and major tumor response. This new therapeutic sequence, combining efficient tumor targeting and subsequent portal vein embolization, could improve the feasibility and safety of major liver resection for hepatocellular carcinoma in patients with liver injury.	Fikri Bouazza Arthur Poncelet Camilo Alejandro Garcia Philippe Delatte Jean Luc Engelhom Maria Gomez Galdon Amélie Deleporte Alain Hendlisz Bruno Vanderlinden Patrick Flamen Vincent Donckier	2015	World Journal of Gastroenterology2015，21，32：	2
2	Correlation between the response to cetuximab alone or in combination with irinotecan and the activated/ phosphorylated epidermal growth factor receptor in metastatic coloreetal cancer 显示文摘	Personeni N Hendlisz A Gallez J	2005	Semin Oncol2005，32，9：	1
3	Treatment of colorectal liver metastases: a review显示文摘	Van den Eynde M Hendlisz A	2009	Rev Recent Clin Trials2009，4，1：	1
4	Treatment of colorectal livermetastases: a review显示文摘	Van den Eynde M Hendlisz A	2009	Rev Recent Clin Trials2009，4，1：	1
5	Modulation and prognostic value of epidermal growth factor receptor (EGFR) expression in circulating tumor cells (CTCs) during chemotherapy (CT) in patients with metastatic colorectal cancer 显示文摘	Hendlisz A Marechal R Durbecq V	2008	J Clin Oncol2008，26，：	1
6	Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours显示文摘	AWADA A HENDLISZ A GIL T	2005	Brit J Can2005，92，10：	1
7	Modulation and prognostic value of epidermal growth factor receptor(EGFR)expression in circulating tumor cells(CTC)during chemotherapy(CT)in patients with metastatic colorectal cancer显示文摘	HENDLISZ A MARECHAL R DURBECQ V	2008	J Clin Oncol2008，26，15：	1
8	Phase Ⅰ safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumors 显示文摘	Awada A Hendlisz A Gil T	2005	Br J Cancer2005，92，10：	1
9	New anticancer agents and therapeutic strategies in development for solid cancers: a clinical perspe显示文摘	Awada A Mano M Hendlisz A	2004	Expert Rev Anticancer Ther2004，4，1：	1
10	New anticancer agents and therapeutic strategies in development for solid cancers: A clinical perspective 显示文摘	Awada A Mano M Hendlisz A	2004	Expert Rev Anticaneer Ther2004，4，1：	1
11	查看详情显示文摘	Deleporte A Flamen P Hendlisz A		0，，：	1
12	Phase I safety and pharmacokineties of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours显示文摘	Awada A Hendlisz A Gil T	2005	Br J Cancer2005，92，10：	1
13	Phase Ⅰ safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced,refractory solid tumours显示文摘	AWADA A HENDLISZ A GIL T	2005	Br J Cancer2005，92，10：	1
14	Treatment of colorectal liver metastases : a review显示文摘	Van den Eynde M Hendlisz A	2009	Rev Recent Clin Trials2009，4，1：	1
15	Treatment of colorectal liver metastases: 1 review显示文摘	Vanden Eynde M Hendlisz A	2009	Rev Recent Clin Trials2009，4，1：	1
16	Inducing Resectability of Chemotherapy Refractory Colorectal Liver Metastasis by Radioembolization With Yttrium-90 Microspheres显示文摘	Marc Van den Eynde Patrick Flamen Issam El Nakadi Gabriel Liberale Philippe Delatte Denis Larsimont Alain Hendlisz	2008	Clinical Nuclear Medicine2008，，：	1
17	Phase I study of pulsatile 3-day administration of afatinib (BIBW 2992) in combination with docetaxel in advanced solid tumors显示文摘	A. H. Awada H. Dumez A. Hendlisz P. Wolter T. Besse-Hammer M. Uttenreuther-Fischer P. Stopfer F. Fleischer M. Piccart P. Sch?ffski	2013	Investigational New Drugs2013，，3：	1
18	Treatment of colorectal liver metasta- ses : a revlew显示文摘	Van den Eynde M Hendlisz A		Rev Recent Clin Trials0，4，1：	1
19	Correlation between the response to cetuximab alone or in combination with irinotecan and the activated/phosphorylated epidermal growth factor receptor in metastatic colorectal cancer显示文摘	Personeni N Hendlisz A Gallez J	2005	Semin Oncol2005，32，9：	1
20	Correlation between the response to cetuximab alone or in combination with irinotecan and the activated/phosphorylated epidermal growth factor receptor in metastatic colorectal cancer显示文摘	Personeni N Hendlisz A Gallez J	2005	Semin Oncol2005，32，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示